BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Staging
49 results:

  • 1.
    Sahin E; Kus T; Aytekin A; Uzun E; Elboga U; Yilmaz L; Cayirli YB; Okuyan M; Cimen V; Cimen U
    J Nucl Med; 2024 Apr; 65(4):512-519. PubMed ID: 38485276
    [TBL] [Abstract] [Full Text] [Related]  

  • 2.
    Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
    J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Head-to-head comparison of
    Zhang J; Jiang S; Li M; Xue H; Zhong X; Li S; Peng H; Liang J; Liu Z; Rao S; Chen H; Cao Z; Gong Y; Chen G; Zhang R; Zhang L
    Cancer Imaging; 2023 Oct; 23(1):106. PubMed ID: 37899452
    [TBL] [Abstract] [Full Text] [Related]  

  • 4.
    Kersting D; Sandach P; Sraieb M; Wiesweg M; Metzenmacher M; Darwiche K; Oezkan F; Bölükbas S; Stuschke M; Umutlu L; Nader M; Hamacher R; Fendler WP; Wienker J; Eberhardt WEE; Schuler M; Herrmann K; Hautzel H
    J Nucl Med; 2023 Oct; 64(10):1540-1549. PubMed ID: 37474272
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of
    Chen X; Wang S; Lai Y; Wang G; Wei M; Jin X; Ding J; Zhang Y; Shi Y; Wang F; Zhu H; Yang Z; Wang X
    J Nucl Med; 2023 Sep; 64(9):1399-1405. PubMed ID: 37385675
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of
    Pang L; Mao W; Zhang Y; Liu G; Hu P; Chen S; Gu Y; Wang Y; Liu H; Shi H
    Abdom Radiol (NY); 2023 Aug; 48(8):2537-2546. PubMed ID: 37179282
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of uptake time on image quality of [
    van der Sar ECA; Viol SLM; Braat AJAT; van Rooij R; Lam MGEH; de Jong HWAM; de Keizer B
    Med Phys; 2023 Dec; 50(12):7619-7628. PubMed ID: 37093883
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Superior Tumor Detection for
    Pabst KM; Trajkovic-Arsic M; Cheung PFY; Ballke S; Steiger K; Bartel T; Schaarschmidt BM; Milosevic A; Seifert R; Nader M; Kessler L; Siveke JT; Lueckerath K; Kasper S; Herrmann K; Hirmas N; Schmidt HH; Hamacher R; Fendler WP
    J Nucl Med; 2023 Jul; 64(7):1049-1055. PubMed ID: 37024301
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Primary tumor SUV
    Tas F; Ozturk A; Erturk K
    Wien Klin Wochenschr; 2023 Sep; 135(17-18):478-487. PubMed ID: 36882606
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Positive Correlation Between 18 F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas.
    Libé R; Pais A; Violon F; Guignat L; Bonnet F; Huillard O; Assié G; Gaillard M; Dousset B; Gaujoux S; Barat M; Dohan A; Sibony M; Bertherat J; Cottereau AS; Tenenbaum F; Coste J; Groussin L
    Clin Nucl Med; 2023 May; 48(5):381-386. PubMed ID: 36758555
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. PET Imaging of Fibroblast Activation Protein in Various Types of cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
    Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H
    Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
    Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
    Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of
    Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H
    Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma.
    Farina A; Gasperini C; Aparisi Gómez MP; Bazzocchi A; Fanti S; Nanni C
    Semin Nucl Med; 2022 Sep; 52(5):635-646. PubMed ID: 34879906
    [TBL] [Abstract] [Full Text] [Related]  

  • 16.
    Mittlmeier LM; Todica A; Gildehaus FJ; Unterrainer M; Beyer L; Brendel M; Albert NL; Ledderose ST; Vettermann FJ; Schott M; Rodler S; Marcon J; Ilhan H; Cyran CC; Stief CG; Staehler M; Bartenstein P
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1711-1720. PubMed ID: 34708249
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Value of
    Yoon HY; Lee SH; Ha S; Ryu JS; Song JW
    J Korean Med Sci; 2021 Oct; 36(41):e257. PubMed ID: 34697928
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study.
    Dutta D; Tatineni T; Yarlagadda S; Gupte A; Reddy SK; Madhavan R; Nair H; Sasidharan A; Kannan R; Pottayil SG; Holla R; Sudhindran S
    Indian J Gastroenterol; 2021 Aug; 40(4):389-401. PubMed ID: 34694581
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using
    Jha A; Patel M; Carrasquillo JA; Ling A; Millo C; Saboury B; Chen CC; Wakim P; Gonzales MK; Meuter L; Knue M; Talvacchio S; Herscovitch P; Rivero JD; Chen AP; Nilubol N; Taïeb D; Lin FI; Civelek AC; Pacak K
    AJR Am J Roentgenol; 2022 Feb; 218(2):342-350. PubMed ID: 34431366
    [No Abstract]    [Full Text] [Related]  

  • 20. Equivalent tumor detection for early and late FAPI-46 PET acquisition.
    Ferdinandus J; Kessler L; Hirmas N; Trajkovic-Arsic M; Hamacher R; Umutlu L; Nader M; Zarrad F; Weber M; Fendler WP
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3221-3227. PubMed ID: 33620560
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.